This exclusive industry event unites the experts in AI/ML innovation, application, and integration to accelerate pipeline workflow – bringing new therapeutics to market with unequivocal efficiency. This event is your opportunity to assess enterprise-wide solutions capable of supporting product discovery and clinical validity.
Why Should You Attend?
- Engage with leading pharma and biotech companies as they discuss the current state of AI-assisted drug discovery and explain how they are adjusting existing processes to drive decisions on AI insights.
- Discuss how AI can be leveraged to support multi-omic data integration.
- Understand how recent advances in AI/ML are improving the accuracy of therapeutic target identification.
- Discover how AI is accelerating drug safety assessments and how researchers are augmenting toxicity predictions through in silico ADMET models.
- Connect with industry leaders using AI/ML to aid drug repositioning efforts for rare disease and learn from SARS-CoV-2 drug repurposing efforts.
- Upskill decision makers and users on AI methodologies and limitations to avoid black box mistrust.
- Identify new AI-native partners and learn to better manage existing partnerships to further integrate AI processes across functions.
